SCNI
SCNI clinical trials: Scinai Immunotherapeutics Ltd.
Every trial on ClinicalTrials.gov where Scinai Immunotherapeutics Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SCNI on the catalyst calendar · SCNI registry changes
- Primary completion Oct 2009ActualPhase 1/Phase 2NCT00877448A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)BiondVax Pharmaceuticals ltd. · HealthyCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2, 2020ActualPhase 3NCT03450915A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu VaccineBiondVax Pharmaceuticals ltd. · InfluenzaCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2016ActualPhase 2NCT02691130Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in AdultsBiondVax Pharmaceuticals ltd. · InfluenzaCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2015ActualPhase 2NCT02293317Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIVBiondVax Pharmaceuticals ltd. · InfluenzaCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2012ActualPhase 2NCT01419925A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly VolunteersBiondVax Pharmaceuticals ltd. · InfluenzaCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2011ActualPhase 2NCT01146119Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)BiondVax Pharmaceuticals ltd. · InfluenzaCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2010ActualPhase 1/Phase 2NCT01010737A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly VolunteersBiondVax Pharmaceuticals ltd. · InfluenzaCompletedSCNILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner